Sands Capital Management - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Sands Capital Management ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$7,535,000
-10.1%
260,0000.0%0.01%
-18.8%
Q1 2021$8,380,000
-22.0%
260,0000.0%0.02%
+60.0%
Q4 2020$10,746,000260,0000.01%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,084,370$30,432,0004.62%
Vivo Capital, LLC 2,312,368$33,761,0003.39%
Frazier Life Sciences Management, L.P. 1,787,527$26,098,0002.46%
Cormorant Asset Management, LP 1,875,000$27,375,0002.07%
Sands Capital Ventures, LLC 260,000$3,796,0001.04%
Ghost Tree Capital, LLC 120,000$1,752,0000.91%
RTW INVESTMENTS, LP 2,013,601$29,399,0000.76%
COWEN AND COMPANY, LLC 534,524$7,804,0000.75%
Perceptive Advisors 1,296,416$18,927,0000.59%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,324,214$19,334,0000.40%
View complete list of TARSUS PHARMACEUTICALS INC shareholders